TrialJournal of cancer research and clinical oncology2018

Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC).

M Faehling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.